Metagenomi Therapeutics, Inc. Common Stock (MGX)

Typically moves ±5.71% on earnings
EARNINGS ANALYTICS
event_note Approx. Next Earnings: ~2026-11-12 APPROXIMATE
search

Metagenomi Therapeutics, Inc. Common Stock (MGX) has reported earnings 11 times since Mar 27, 2024. The stock moves an average of ±5.71% the day after reporting, closing higher 27.3% of the time. Its largest post-earnings gain was +3.83% (May 14, 2024) and its largest decline was -15.07% (Nov 12, 2025). The next earnings report is predicted for 2026-11-12 (approximate).

Earnings reactions

How MGX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

11

Avg Abs. Movement

±5.71%

Positive %

27.3%

Negative %

72.7%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 10, 2026 ☽ POST -0.41% open_in_new
May 11, 2026 ☽ POST +0.37% open_in_new
Mar 05, 2026 ☽ POST -7.19% open_in_new
Nov 12, 2025 ☀ PRE -15.07% open_in_new
event

Earnings Count

11

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.71%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 9 →
9
Funds holding
$1015425
Total value held
Buying
4 added · 3 reduced
Wells Fargo & Company/Mn
$451614 +87.75%
Blackrock, Inc.
$306581 +11.95%
State Street Corp
$142622 -0.48%
Northern Trust Corp
$82036 -8.29%
Ubs Group Ag
$18794 NEW BUY

Frequently asked about MGX earnings

When does Metagenomi Therapeutics, Inc. Common Stock report earnings next? expand_more

Metagenomi Therapeutics, Inc. Common Stock (MGX)'s next earnings date is approximate for 2026-11-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does MGX stock move after earnings? expand_more

Over 11 reports, MGX has moved an average of ±5.71% the session after earnings, closing higher 27.3% of the time.

What was MGX's biggest post-earnings move? expand_more

MGX's largest post-earnings gain on record was +3.83% on May 14, 2024, and its largest decline was -15.07% on Nov 12, 2025.

Where can I find Metagenomi Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Metagenomi Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.